| Sex: F (%)/M (%) | 102 (51%)/98 (49%) | Age (years) | 74.3 ± 14.8 [21–97] | Platelet count (mcl) | 241460 ± 90000 [54000–638000] | Bilirubin (mg/dl) | 3.05 ± 4.1 [0.32–24.6] | Alkaline phosphatase (UI/ml) | 308 ± 258 [43–1602] | GGT (UI/ml) | 517 ± 430 [14–2018] | INR | 1.03 ± 0.15 [0.8–1.8] |
| ERCP indication, n (%) | Cholangitis, 67/200 (33.5%) | Jaundice, 21/200 (11.5%) | Pain, 19/200 (9.5%) | Pancreatitis, 12/200 (6%) | Cholangitis-pancreatitis, 4/200 (2%) |
| ASA classification, n (%) | ASA 1, 24/200 (12%) | ASA 2, 70/200 (35%) | ASA 3, 82/200 (41%) | ASA 4, 24/200 (12%) |
| Number of stones, n (%) | 1 stone, 71/200 (35.5%) | 2 stones, 32/200 (16%) | 3–5 stones, 38/200 (19%) | 6–10 stones, 34/200 (17%) | >10 stones, 25/200 (12.5%) |
| Stone size (mm) | 13.5 ± 4.7 [5–40] | CBD size (mm) | 14.1 ± 5.9 [6–40] |
| ERCP difficulty, n (%) | Grade 1, 0/200 (0%) | Grade 2, 52/200 (26%) | Grade 3, 138/200 (69%) | Grade 4, 10/200 (5%) |
| PAD, n (%) | 34/200 (17%) | Billroth II gastrectomy, n (%) | 8/200 (4%) | Previous EST, n (%) | 75/200 (37.5%) | Need for precut EST, n (%) | 9/200 (4.5%) | Need for ML, n (%) | 13/200 (6.5%) | Diameter of dilatation (mm) | 14.1 ± 2 [8–19] |
|
|